Hartland & Co »

Lexeo Therapeutics shares owned by Hartland & Co

Quarter-by-quarter ownership of Lexeo Therapeutics (LXEO) shares owned by Hartland & Co from 13F filings

Historical chart of Hartland & Co investment in Lexeo Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Lexeo Therapeutics held by Hartland & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lexeo Therapeutics by Hartland & Co

Quarter filed Position value Share count Share price at filing
2025-09-30 $2.0k 304 6.64

More positions owned by Hartland & Co

Vanguard Index Fds S&p 500 Etf Shs Put Option (Principal) (VOO)
Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Rus 1000 Grw Etf (IWF)
Apple (AAPL)
Vanguard Index Fds Mid Cap Etf (VO)
Microsoft Corporation (MSFT)
Vanguard Index Fds Small Cp Etf (VB)
Vanguard Index Fds Value Etf (VTV)
Spdr Index Shs Fds Portfolio Devlpd (SPDW)
Vanguard Scottsdale Fds Mtg-bkd Secs Etf (VMBS)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Dimensional Etf Trust Intl Core Eqt Mk (DFAI)
NVIDIA Corporation (NVDA)
Wisdomtree Tr Us Largecap Divd (DLN)
Spdr S&p 500 Etf Tr Tr Unit (SPY)

View all positions for Hartland & Co

Top funds holding Lexeo Therapeutics

Henderson Group
Frazier Life Sciences Management
Balyasny Asset Management
Affinity Asset Advisors
Citadel Advisors
Vestal Point Capital
Woodline Partners
Millennium Management
Vanguard Group
BlackRock
Point72 Asset Management
ADAR1 Capital Management
Blackstone Group
D1 Capital Partners
683 Capital Management

View all funds holding Lexeo Therapeutics